Moreover, it has been described that IL6, TNF-α, and IL-1β lead to activation of the NF-kB pathway, which is the major controller of pulmonary fibrosis and epithelial–mesenchymal transition, in response to chronic inflammation [55]. The gene discussed is IL6; the disease is pulmonary fibrosis.